About IAC
A-Z Index
Immunization Action Coalition

Vaccine-Related Journal Articles

Topics of Interest: Potential new vaccines

Potential New Vaccines 2015-2010
Efficacy and Safety of RTS,S/AS01 Malaria Vaccine with or without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial
Author: RTS,S Clinical Trials Partnership
Source: Lancet, April 23, 2015, Vol. S0140-6736(15)60721-8
The Human Hookworm Vaccine: Recent Updates and Prospects for Success
Author: Bottazzi ME
Source: J Helminthol, e-published April 8, 2015
Acceptability of a Hypothetical Group B Strep Vaccine among Pregnant and Recently Delivered Women
Authors: Dempsey AF, Pyrzanowski J, Donnelly M, et al.
Source: Vaccine, May 1, 2014, Vol. 32(21):2463-8
Update on the Development of TB Vaccines
Author: Zenteno-Cuevas R
Source: Curr Pharm Biotechnol, November 2013, Vol. 14(11):940-6
Staphylococcal Vaccine Development: Review of Past Failures and Plea for a Future Evaluation of Vaccine Efficacy Not Only on Staphylococcal Infections but Also on Mucosal Carriage
Authors: Botelho-Nevers E, Verhoeven P, Paul S, Grattard F, Pozzetto B, Berthelot P, Lucht F
Source: Expert Rev Vaccines, November 2013, Vol. 12(11):1249-59
Preventing the Broad Spectrum of Perinatal Morbidity and Mortality through Group B Streptococcal Vaccination
Authors: Edwards MS, Gonik B
Source: Vaccine, August 28, 2013, Vol. 31 Suppl 4:D66-71
Advances in the Development of Vaccines for Alzheimer's Disease
Authors: Lambracht-Washington D, Rosenberg RN
Source: Discov Med, May 2013, Vol. 15(84):319-26
Delivering the Promise of the Decade of Vaccines: Opportunities and Challenges in the Development of High Quality New Vaccines
Authors: Keith JA, Agostini Bigger L, Arthur PA, Maes E, Daems R
Source: Vaccine, April 18, 2013, Vol. 18;31 Suppl 2:B184-93
Development of a Highly Efficacious Vaccinia-based Dual Vaccine Against Smallpox and Anthrax, Two Important Bioterror Entities
Authors: Tod J. Merkel, Pin-Yu Perera, Vanessa K. Kelly, et al.
Source: PNAS, 2010, Vol. 107 (42): 18091-6
Progress towards Development of an HIV Vaccine: Report of the AIDS Vaccine 2009 Conference
Authors: Ross AL, Brave A, Scarlatti G, Manrique A, Buonaguro L
Source: Lancet Infect Dis, May 2010, Vol. 10(5):305-16
DNA Vaccines: A Rational Design against Parasitic Diseases
Authors: Carvalho JA, Rodgers J, Atouguia J, Prazeres DM, Monteiro GA
Source: Expert Rev Vaccines, February 2010, Vol. 9(2):175-91
Alternative Approaches to Vaccine Delivery
Authors: Wang L, Ma C, Coppel RL
Source: Hum Vaccin, January 21, 2010, Vol. 6(1)
back to top
Potential New Vaccines 2009
Neglected Tropical Disease Vaccines
Authors: Hotez PJ, Brown AS
Source: Biologicals, March 10, 2009
Reflections on Early Malaria Vaccine Studies, the First Successful Human Malaria Vaccination, and Beyond
Author: Vanderberg JP
Source: Vaccine, January 1, 2009, Vol. 27(1):2-9
back to top
Potential New Vaccines 2008
Model for Product Development of Vaccines against Neglected Tropical Diseases: A Vaccine against Human Hookworm
Authors: Bottazzi ME, Brown AS
Source: Expert Rev Vaccines, December 2008, Vol. 7(10):1481-92
New Generation of Inactivated Poliovirus Vaccines for Universal Immunization after Eradication of Poliomyelitis
Authors: Chumakov K, Ehrenfeld E
Source: Clin Infect Dis, December 15, 2008, Vol. 47(12):1587-92
Inactivated Rotavirus Vaccines: A Priority for Accelerated Vaccine Development
Authors: Jiang B, Gentsch JR, Glass RI.
Source: Vaccine, December 9, 2008, Vol. 26(52):6754-8
First Generation Leishmaniasis Vaccines: A Review of Field Efficacy Trials
Authors: Noazin S, Modabber F, Khamesipour A, et al.
Source: Vaccine, December 9, 2008, Vol. 26(52):6759-67
DNA Vaccines: Developing New Strategies to Enhance Immune Responses
Authors: Abdulhaqq SA, Weiner DB
Source: Immunol Res, December 6, 2008
New Horizons in Adjuvants for Vaccine Development
Authors: Reed SG, Bertholet S, Coler RN, Friede M
Source: Trends Immunol, December 5, 2008
Group B Streptococcal Conjugate Vaccine: A Timely Concept for Which the Time Has Come
Author: Edwards MS
Source: Hum Vaccin, November-December 2008, Vol. 4(6):444-8
Is Intranasal Vaccination a Feasible Solution for Tuberculosis?
Authors: Giri PK, Khuller GK
Source: Expert Rev Vaccines, November 2008, Vol. 7(9):1341-56
Novel Vaccines: Bridging Research, Development and Production
Authors: Demirjian A, Levy O
Source: Expert Rev Vaccines, November 2008, Vol. 7(9):1321-4
Personalized Vaccines: The Emerging Field of Vaccinomics
Authors: Poland GA, Ovsyannikova IG, Jacobson RM
Source: Expert Opin Biol Ther, November 2008, Vol. 8(11):1659-67
How Could We Have Better Vaccines against Tuberculosis?
Author: Giri PK
Source: Expert Opin Biol Ther, November 2008, Vol. 8(11):1759-72
The End of the Beginning: Vaccines for the Next 25 Years
Author: Oxford JS
Source: Vaccine, November 18, 2008, Vol. 26(49):6179-82
Measles Vaccination: New Strategies and Formulations
Authors: de Vries RD, Stittelaar KJ, Osterhaus AD, de Swart RL
Source: Expert Rev Vaccines, October 2008, Vol. 7(8):1215-23
Recent Progress in the Development of Plant Derived Vaccines
Authors: Yusibov V, Rabindran S
Source: Expert Rev Vaccines, October 2008, Vol. 7(8):1173-83
Improving Vaccine Delivery Using Novel Adjuvant Systems
Author: Pichichero ME
Source: Hum Vaccin, July-August 2008, Vol. 4(4):262-70
Tuberculosis: Vaccines in the Pipeline
Authors: Ly LH, McMurray DN
Source: Expert Rev Vaccines, July 2008, Vol. 7(5):635-50
Tuberculosis Vaccine Development: Goals, Immunological Design, and Evaluation
Author: Hoft DF
Source: Lancet, July 12, 2008, Vol. 372(9633):164-75
Current Progress of DNA Vaccine Studies in Humans
Authors: Lu S, Wang S, Grimes-Serrano JM
Source: Expert Rev Vaccines, March 2008, Vol. 7(2):175-91
back to top
Potential New Vaccines 2007
Safety of the RTS,S/AS02D Candidate Malaria Vaccine in Infants Living in a Highly Endemic Area of Mozambique: A double blind randomised controlled phase I/IIb trial
Authors: Aponte JJ, Aide P, Renom M, et al
Source: Lancet, October 17, 2007; [Epub ahead of print]
Oral Vaccination: Where we are?
Authors: Silin DS, Lyubomska OV, Jirathitikal V, Bourinbaiar AS
Source: Expert Opin Drug Deliv, July 2007;4 (4):323-340
Vaccines against Pandemic Influenza
Authors: Dutton RW, Swain SL, Woodland DL
Source: Viral Immunol, Summer 2007; 20(2):326-327
Current Status of TB Vaccines
Authors: Gupta UD, Katoch VM, McMurray DN.
Source: Vaccine, May 10, 2007; 25(19):3742-3751
back to top
Potential New Vaccines 2006
A Review of Vaccine Research and Development: The Human Immunodeficiency Virus (HIV) Authors: Girard MP, Osmanov SK, Kieny MP
Source: Vaccine, May 8, 2006, Vol. 24(19):4062-5081
The Potential of Human Papillovirus Vaccines
Author: Steinbrook R
Source: New England Journal of Medicine, March 16, 2006, Vol. 354(11):1109-1112
Preventing Cervical Cancer in the Developing World
Authors: Katz IT, Wright AA
Source: New England Journal of Medicine, March 16, 2006, Vol. 354(11):1110
A Review of Vaccine Research and Development: Meningococcal Disease
Authors: Girard MP, Preziosi MP, Aguado MT, Kieny MP
Source: Vaccine, March 31, 2006, Epub
Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases
Authors: Frazer IH, Cox JT, Mayeaux EJ Jr, et al
Source: Pediatr Infect Dis J, Feb. 2006, Vol. 25(2 Suppl):S65-81, quiz S82
New Vaccines against Infectious Diseases: Research and Development Status
Source: World Health Organization, February 2006
back to top
Potential New Vaccines 2005
Pediatricians' Intention to Administer Human Papillomovirus Vaccine: The Role of Practice Characteristics, Knowledge, and Attitudes
Authors: Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL
Source: Journal of Adolescent Health, December 2005, Vol. 37(6):502-510
Vaccination as a Prevention Strategy for Human Papillomavirus-Related Diseases
Author: Kahn JA
Source: J Adolesc Health, Dec. 2005, Vol. 37(6 Suppl):S10-16
Improving Adolescent Health: Focus on HPV Vaccine Acceptance
Author: Zimet GD
Source: J Adolesc Health, Dec. 2005, Vol. 37(6 Suppl):S17-23
Attitudes about Human Papillomavirus Vaccine among Family Physicians
Authors: Riedesel JM, Rosenthal SL, Zimet GD, et al
Source: J Pediatr Adolesc Gynecol, Dec. 2005, Vol. 18(6):391-398
Report of Meeting on the Development of Influenza Vaccines with Broad Spectrum and Long-Lasting Immune Responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004
Authors: Cassetti MC, Couch R, Wood J, Pervikov Y
Source: Vaccine, February 18, 2005, Vol. 23(13):1529-1533
Parental Attitudes About Sexually Transmitted Infection Vaccination for their Adolescent Children
Authors: Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE
Source: Archives of Pediatric and Adolescent Medicine, February 2005, Vol. 159(2):132-7
back to top
Potential New Vaccines 2004
Gynecologists' Attitudes Regarding Human Papilloma Virus Vaccination: A Survey of Fellows of the American College of Obstetricians and Gynecologists
Authors: Raley JC, Followwill KA, Zimet GD, Ault KA
Source: Infect Dis Obstet Gynecol, September-December 2004, Vol. 12(3-4):127-133
Human Papillomavirus and Cervical Cancer
Authors: Unger ER, Barr E
Source: Emerging Infectious Diseases, November 2004, Vol. 10(11):2031-2032
Vaccines Administered Simultaneously: Directions for New Combination Vaccines Based on an Historical Review of the Literature
Authors: Fletcher MA, Fabre P, Debois H, Saliou P
Source: International Journal of Infectious Diseases, November 2004, Vol. 8(6):328-338
Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice
Authors: Guebre-Zabier M, Hammond SA, Ellingsworth LR, Glenn GM
Source: Journal of Virology, July 2004, Vol. 78(14):7610-7618
Progress on New Vaccine Strategies for the Immunotherapy and Prevention of Cancer
Authors: Berzofsky JA, Terabe M, Oh S, et al.
Source: Journal of Clinical Investigation, June 2004, Vol. 113(11):1515-1525
Vaccines for Conformational Disorders
Authors: Sadowski M, Wisniewski T
Source: Expert Review of Vaccines, June 2004, Vol. 3(3):279-290
Technologies that Make Administration of Vaccines Safer
Authors: Clements CJ, Larsen G, Jodar L
Source: Vaccine, May 7, 2004, Vol. 22(15-16):2054-8
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.